Zhang Y.; Nasto R.; Varghese R.; Jablonski S.; Serebriiskii I.; Surana R.; Calvert V.; Bebu I.; Murray J.; Jin L.; Johnson M.; Riggins R.; Ressom H.; Petricoin E.; Clarke R.; Golemis E.; Weiner L.
(2016)
© 2016 Macmillan Publishers Limited.Resistance to therapies targeting the estrogen pathway remains a challenge in the treatment of estrogen receptor-positive breast cancer. To address this challenge, a systems biology ...